From: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
miRNA | Fold change | P-value | Probability, that gene is differentially expressed |
---|---|---|---|
hsa-miR-760 | 169.628 | < 0.000001 | 100.000% |
hsa-miR-381 | 0.002 | < 0.000001 | 100.000% |
hsa-miR-378 | 37.596 | < 0.000001 | 100.000% |
hsa-miR-151-3p | 35.734 | < 0.000001 | 100.000% |
hsa-miR-629 | 45.790 | < 0.000001 | 100.000% |
hsa-miR-150 | 0.020 | < 0.000001 | 100.000% |
hsa-miR-219-5p | 0.032 | < 0.000001 | 99.999% |
hsa-miR-26b* | 41.191 | < 0.000001 | 99.999% |
hsa-miR-302b | 0.057 | < 0.000001 | 99.997% |
hsa-miR-19b-1* | 36.432 | < 0.000001 | 99.994% |
hsa-miR-126* | 9.317 | < 0.000001 | 99.972% |
hsa-let-7f | 0.011 | < 0.000001 | 99.968% |
hsa-miR-571 | 30.947 | < 0.000001 | 99.978% |
hsa-miR-29c* | 23.842 | < 0.000001 | 99.976% |
hsa-miR-625* | 13.286 | < 0.000001 | 99.938% |
hsa-let-7a | 0.014 | < 0.000001 | 99.922% |
hsa-miR-134 | 40.828 | < 0.000001 | 99.846% |
hsa-miR-320 | 4.533 | < 0.000001 | 99.811% |
hsa-miR-451 | 0.225 | < 0.000001 | 99.723% |
hsa-miR-19a | 0.261 | < 0.000001 | 99.651% |
hsa-miR-365 | 16.768 | < 0.000001 | 99.642% |
hsa-miR-339-3p | 10.606 | < 0.000001 | 99.524% |
hsa-miR-203 | 79.565 | < 0.000001 | 98.908% |
hsa-miR-302c | 0.044 | < 0.000001 | 98.729% |
hsa-miR-454* | 11.965 | < 0.000001 | 97.193% |
hsa-miR-144* | 6.425 | < 0.00001 | 92.206% |
hsa-miR-655 | 10.716 | < 0.00001 | 84.080% |
hsa-miR-367 | 0.133 | < 0.00001 | 81.739% |
hsa-miR-425* | 6.666 | < 0.0001 | 79.234% |
hsa-miR-142-5p | 0.136 | < 0.0001 | 74.933% |